ArticleThe Lancet. Respiratory medicine2021

Subcutaneous interferon beta-1a in COVID-19: raking the ashes of an intervention trial.

Tom WilkinsonPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.